AVADEL PHARMACEUTICALS

Avadel Pharmaceuticals plc (Nasdaq:AVDL) is a specialty pharmaceutical company that seeks to develop differentiated pharmaceutical products that are safe, effective and easy to take through formulation development, by utilizing its proprietary drug delivery technology and through in-licensing / acquiring new products; ultimately, helping patients adhere to their prescribed medical treatment and see better results. Avadel’s current portfolio of products and product candidates focuses on the urology, central nervous system (CNS) / sleep, and hospital markets. The Company is headquartered in Dublin, Ireland with operations in St. Louis, Missouri and Lyon, France. For more information, please visit www.avadel.com.

#SimilarOrganizations #People #Financial #Event #Website #More

AVADEL PHARMACEUTICALS

Social Links:

Linkedin

Twitter

Industry:

Biotechnology Information Technology Manufacturing Pharmaceutical

Founded:

1990-01-01

Address:

Dublin, Dublin, Ireland

Country:

Ireland

Website Url:

http://www.avadel.com

Total Employee:

101+

Status:

Active

Contact:

(636) 449-1830

Email Addresses:

[email protected]

Total Funding:

190 M USD

Technology used in webpage:

Apple Mobile Web Clips Icon IPv6 Organization Schema COVID-19 Amazon Route 53 Ruby On Rails Token Amazon S3 CDN OpenResty Microsoft Azure ContactPoint Schema

Similar Organizations

exceller-logo

EXCELLER

EXCELLER is a business development company focusing on life science technology.

ferring-pharmaceuticals-logo

Ferring Pharmaceuticals

Ferring is a biopharmaceutical company dedicated to the development of innovative treatments that make a real difference in people’s lives.

nephrodi-therapeutics-logo

NephroDI Therapeutics

NephroDI Therapeutics is a biopharmaceutical company that focuses on the concentration disorders of the kidney.

Current Employees Featured

douglas-williamson_image

Douglas Williamson
Douglas Williamson Chief Medical Officer @ Avadel Pharmaceuticals
Chief Medical Officer
2022-02-01

thomas-s-mchugh_image

Thomas S . McHugh
Thomas S . McHugh Chief Financial Officer @ Avadel Pharmaceuticals
Chief Financial Officer
2019-12-01

greg-divis_image

Greg Divis
Greg Divis Chief Executive Officer @ Avadel Pharmaceuticals
Chief Executive Officer
2019-01-01

Stock Details

Company's stock symbol is NASDAQ:AVDL

Investors List

frazier-healthcare-ventures_image

Frazier Healthcare Partners

Frazier Healthcare Partners investment in Post-IPO Equity - Avadel Pharmaceuticals

rtw-investments-llc_image

RTW Investments

RTW Investments investment in Post-IPO Equity - Avadel Pharmaceuticals

vivo-capital_image

Vivo Capital

Vivo Capital investment in Post-IPO Equity - Avadel Pharmaceuticals

acuta-capital-partners_image

Acuta Capital Partners

Acuta Capital Partners investment in Post-IPO Equity - Avadel Pharmaceuticals

kvp-capital_image

KVP Capital

KVP Capital investment in Post-IPO Equity - Avadel Pharmaceuticals

avoro-capital-advisors_image

Avoro Capital Advisors

Avoro Capital Advisors investment in Post-IPO Equity - Avadel Pharmaceuticals

venrock-healthcare-partners_image

Venrock Healthcare Capital Partners

Venrock Healthcare Capital Partners investment in Post-IPO Equity - Avadel Pharmaceuticals

Key Employee Changes

Date	New article
2022-02-14	Avadel Pharmaceuticals Appoints Dr. Douglas Williamson as Chief Medical Officer

Official Site Inspections

http://www.avadel.com Semrush global rank: 10.12 M Semrush visits lastest month: 257

Host Informations
Whois Informations

Loading ...

More informations about "Avadel Pharmaceuticals"

linkstock.net © 2022. All rights reserved